Elite Pharmaceuticals (QB) Stock Price

0.00136 (2.38%)
Best deals to access real time data!
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
Canna Trader Pro
Monthly Subscription
for only
Small Cap Basic
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type
Elite Pharmaceuticals Inc (QB) ELTP OTCMarkets Common Stock
  Price Change Change Percent Stock Price Last Traded
0.00136 2.38% 0.0586 15:59:26
Open Price Low Price High Price Close Price Prev Close
0.055 0.0521 0.06 0.0586 0.05724
Bid Price Ask Price Spread News
0.056 0.06 0.004 - -
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
130 2,678,645 $ 0.054519 $ 146,037 - 0.048 - 0.10
Last Trade Time Type Quantity Stock Price Currency
15:59:26 1,793 $ 0.0586 USD

Elite Pharmaceuticals (QB) Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 59.14M 1.01B 793.80M $ - $ - - -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
3.46k $ - 0.00% - -

more financials information »

Elite Pharmaceuticals (QB) News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical ELTP Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week0.060.0640.05210.0591254879,940-0.0014-2.33%
1 Month0.06950.09240.05210.07004832,504,845-0.0109-15.68%
3 Months0.054250.09240.048050.06268571,745,8300.004358.02%
6 Months0.07650.09240.0480.06193181,340,661-0.0179-23.4%
1 Year0.080.100.0480.06719091,053,855-0.0214-26.75%
3 Years0.1050.1410.03330.0799146848,335-0.0464-44.19%
5 Years0.300.3950.03330.1287906970,255-0.2414-80.47%

Elite Pharmaceuticals (QB) Description

Elite Pharmaceuticals, Inc. is a specialty pharmaceutical company focused on the development, manufacturing, and packaging of niche generic products, which are then distributed by exclusive marketing partners. Elite specializes in oral sustained and controlled release drug products that have high barriers to entry. Elite owns generic products which have been licensed to TAGI Pharma, Glenmark Pharmaceuticals, Inc., USA., and Lannett Company, Inc. Elite currently has eleven approved generic products, two which are pending launch, another two generic products are filed with the FDA, and an NDA filed for SequestOx(TM). Elite operates a GMP and DEA registered facility for research, development, and manufacturing located in Northvale, NJ. Learn more at www.elitepharma.com.

Your Recent History
Elite Phar..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.